Adopting cutting-edge technology is playing a vital role now more than ever in the digital revolution of the pharmaceutical industry, with any advancement that may offer improvement quickly becoming a big focus.

World-leading A-Z service companies such as QUINTA-ANALYTICA are constantly adopting more tech and embracing new technologies that are proving critical to revolutionizing research, attracting patients for trials, and reducing the speed of delivering results.

Technologies like Artificial Intelligence (AI), Machine Learning (ML), and digital apps, are allowing pharmaceutical companies to not only improve their access to vital medical and patient information but improve their accuracy and capability.

With AI already being used in the healthcare industry while conducting repetitive tasks such as data entry, lab test analyses, and data management to identify errors or inefficiencies, and ML being used in disease identification and diagnosis, clinical trial research, and new drug invention, it’s clear that tech is ingrained in an irreversible way.

Further used to improve operational, regulatory, and financial performance, the answer is certain that in modern companies like Quinta, tech undoubtedly helps pharma.

Additional News

  • 9 July 2025

    HER-096: A possible breakthrough in Parkinson’s disease treatment

    This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson’s disease.

  • 9 June 2025

    Ensuring Success in Buccal Film Development: The Midazolam Film Case Study

    Fast, Simple, Effective: Unlocking the Potential of Midazolam Films

  • 15 May 2025

    From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.